About: Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years of age; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 15 years of age. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $1.98 (+0.51%)
AYTU NASDAQ Aytu BioScience Inc
Aytu BioScience Inc share price
Atividade de preço de AYTU
Último preço
$ 1,980
Variação (24h)
0,01 USD (0,51%)
Volume
9.28K
Volume (média 4 sem.)
-
Abertura
$ 1,95
Variação do dia
$ 1,95 - $ 1,99
Fechamento anterior
$ 1,97
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
AYTU price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals